Reliance Pharma Fund (Bonus)
56.829
0.23 (0.40%)
NAV as on May-25-2012
Fund Family Reliance Mutual Fund
Fund Class Sector - Pharma & Healthcare
SNAPSHOT
Performance
Investment Info
Peers
Portfolio
News and Videos
Not Ranked
This scheme is not ranked by CRISIL.
View Top ranked funds in other categories
Benchmark Index:
Returns (NAV as on May-25-2012)
| Period | Returns (%) | Rank # |
|---|---|---|
| 1 mth | -2.6 | 2 |
| 3 mth | 6.0 | 2 |
| 6 mth | 8.1 | 2 |
| 1 year | 3.4 | 2 |
| 2 year | 7.9 | 3 |
| 3 year | 31.8 | 1 |
| 5 year | 19.9 | 1 |
# Moneycontrol Rank within Sector - Pharma & Healthcare Schemes.
Absolute Returns (in %)
| Year | Qtr 1 | Qtr 2 | Qtr 3 | Qtr 4 | Annual |
|---|---|---|---|---|---|
| 2012 | 8.6 | - | - | - | - |
| 2011 | -8.0 | 7.5 | -7.5 | -4.2 | -11.6 |
| 2010 | 11.0 | 8.7 | 0.9 | 6.6 | 32.0 |
| 2009 | -5.4 | 33.0 | 40.9 | -0.2 | 116.7 |
| 2008 | -29.1 | 0.6 | 3.4 | -10.6 | -35.0 |
| 2007 | -4.3 | 31.2 | -2.7 | 18.5 | 47.8 |
* Returns over 1 year are Annualised
Performance
Fund returns v/s Category average (Sector - Pharma & Healthcare)
* Returns over 1 year are Annualised
| 1 mth (%) | 3 mth (%) | 6 mth (%) | 1 yr (%) | 2 yr (%) | 3 yr (%) | 5yr (%) | |
| Fund Returns | -2.6 | 6.0 | 8.1 | 3.4 | 7.9 | 31.8 | 19.9 |
| Category avg | -2.3 | 5.8 | 7.2 | 5.1 | 9.8 | 27.1 | 12.9 |
| Difference of Fund returns and Category returns | -0.3 | 0.2 | 0.9 | -1.7 | -1.9 | 4.7 | 7.0 |
| Best of category | -1.4 | 7.8 | 10.3 | 10.3 | 12.7 | 31.8 | 19.9 |
| Worst of category | -2.8 | 3.5 | 3.1 | 1.5 | 7.9 | 23.9 | 6.6 |
| Benchmark returns # | -1.9 | 6.3 | 11.9 | 10.0 | 12.7 | 24.1 | 12.1 |
| Difference of Fund returns and Benchmark returns | -0.7 | -0.3 | -3.8 | -6.6 | -4.8 | 7.7 | 7.8 |
# Benchmark Index: BSE HEALTHCARE
Investment Info
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Scheme details
| Fund Type | Open-Ended |
|---|---|
| Investment Plan | Bonus |
| Launch date | May 26, 2004 |
| Benchmark | BSE HEALTHCARE |
| Asset Size (Rs cr) | 563.56 (Mar-31-2012) |
| Minimum Investment | Rs.5000 |
| Last Dividend | N.A. View Dividend History |
| Bonus | N.A. |
| Fund Manager | Sailesh Raj Bhan View performance of schemes managed by the Fund Manager |
| Notes | N.A |
Load Details
| Entry Load | N.A |
|---|---|
| Exit Load | 1.00% |
| Load Comments | Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment. |
Contact Details
| Regd. Office | Kamala Mills Compound, Trade World, B-Wing, Senapati Bapat Marg, Lower Parel (W), Mumbai, 400013 |
|---|---|
| Tel. No. | 022-30994600 |
| Fax No. | 91 22 30414899 |
| response@reliancemutual.com | |
| Website | http://www.reliancemutual.com/ |
Peer Comparison
| Sector - Pharma & Healthcare | Crisil Rank | Assets (Rs.cr) |
|||||
| 3mth (%) | 6mth (%) | 1yr (%) | 3yr (%) | 5yr (%) | |||
| Reliance Pharma Fund (G) | Not Ranked |
563.56 | 6.0 | 8.1 | 3.4 | 31.8 | 19.9 |
| SBI Magnum Pharma Fund (G) | Not Ranked |
41.05 | 7.8 | 10.3 | 10.3 | 25.5 | 6.6 |
| UTI Pharma & Health (G) | Not Ranked |
93.37 | 3.5 | 3.1 | 1.5 | 23.9 | 12.3 |
| * Returns over 1 year are Annualised | More » | ||||||
Portfolio
Top Holdings (Apr 30, 12)
| Equity | Sector | Value (Rs cr) |
Asset % |
|---|---|---|---|
| Divis Labs | Pharmaceuticals | - | 11.48 |
| Ranbaxy Labs | Pharmaceuticals | - | 8.43 |
| Aventis Pharma | Pharmaceuticals | - | 8.22 |
| Sun Pharma | Pharmaceuticals | - | 7.08 |
| Ipca Labs | Pharmaceuticals | - | 5.92 |
| Indoco Remedies | Pharmaceuticals | - | 5.84 |
| Cipla | Pharmaceuticals | - | 5.75 |
| Abbott India | Pharmaceuticals | - | 5.41 |
| GlaxoSmithKline | Pharmaceuticals | - | 4.98 |
| Cadila Health | Pharmaceuticals | - | 4.78 |
Sector Allocation (Apr 30, 12)
| Sector | % | 1-Year HighLow |
|
|---|---|---|---|
| Pharmaceuticals | 93.07 | 95.97 | 91.67 |
| Food & Beverage | 3.63 | 3.83 | 2.43 |
Asset Allocation (%)(Apr 30, 12)
| Equity | 96.70 |
| Others | 1.28 |
| Debt | 0.00 |
| Mutual Funds | N.A |
| Money Market | 0.00 |
| Cash / Call | 2.02 |
Concentration
| Holdings | (%) |
|---|---|
| Top 5 | 41.13 |
| Top 10 | 67.89 |
| Sector | (%) |
|---|---|
| Top 3 | 96.70 |
News & Videos
News
Reliance MF schemes emerge as top 3 performers for Q1-2012
May 02, 2012 at 10:44 | Source:
Videos
-
Oct 25, 2011
-
Oct 25, 2011
-
Oct 25, 2011
Messages & Community
Related Searches
Quick Links